51 related articles for article (PubMed ID: 7826368)
1. Enhanced E-cadherin expression in epidermal growth factor receptor expressing cells.
Sorscher SM; Green MR; Feramisco JR
Biochem Biophys Res Commun; 1995 Jan; 206(2):518-24. PubMed ID: 7826368
[TBL] [Abstract][Full Text] [Related]
2. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
Bremm A; Walch A; Fuchs M; Mages J; Duyster J; Keller G; Hermannstädter C; Becker KF; Rauser S; Langer R; von Weyhern CH; Höfler H; Luber B
Cancer Res; 2008 Feb; 68(3):707-14. PubMed ID: 18245470
[TBL] [Abstract][Full Text] [Related]
3. Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-catenin, and epidermal growth factor receptor in cervical cancer cells.
Moon HS; Choi EA; Park HY; Choi JY; Chung HW; Kim JI; Park WI
Gynecol Oncol; 2001 Jun; 81(3):355-9. PubMed ID: 11371122
[TBL] [Abstract][Full Text] [Related]
4. Ligand activation of overexpressed epidermal growth factor receptor results in colony dissociation and disturbed E-cadherin function in HSC-1 human cutaneous squamous carcinoma cells.
Fujii K; Furukawa F; Matsuyoshi N
Exp Cell Res; 1996 Feb; 223(1):50-62. PubMed ID: 8635495
[TBL] [Abstract][Full Text] [Related]
5. Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion.
Takahashi K; Suzuki K
Exp Cell Res; 1996 Jul; 226(1):214-22. PubMed ID: 8660958
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes.
Wilding J; Vousden KH; Soutter WP; McCrea PD; Del Buono R; Pignatelli M
Cancer Res; 1996 Nov; 56(22):5285-92. PubMed ID: 8912870
[TBL] [Abstract][Full Text] [Related]
7. Differential responses of EGFR-/AGT-expressing cells to the "combi-triazene" SMA41.
Matheson SL; McNamee JP; Jean-Claude BJ
Cancer Chemother Pharmacol; 2003 Jan; 51(1):11-20. PubMed ID: 12497201
[TBL] [Abstract][Full Text] [Related]
8. T-cadherin enhances cell-matrix adhesiveness by regulating beta1 integrin trafficking in cutaneous squamous carcinoma cells.
Mukoyama Y; Utani A; Matsui S; Zhou S; Miyachi Y; Matsuyoshi N
Genes Cells; 2007 Jun; 12(6):787-96. PubMed ID: 17573778
[TBL] [Abstract][Full Text] [Related]
9. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
Li J; Ma C; Huang Y; Luo J; Huang C
Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
[TBL] [Abstract][Full Text] [Related]
10. EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells.
Mateus AR; Seruca R; Machado JC; Keller G; Oliveira MJ; Suriano G; Luber B
Hum Mol Genet; 2007 Jul; 16(13):1639-47. PubMed ID: 17510211
[TBL] [Abstract][Full Text] [Related]
11. Kinase-deficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation.
Qian X; Dougall WC; Hellman ME; Greene MI
Oncogene; 1994 May; 9(5):1507-14. PubMed ID: 7908733
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin binding modulates EGF receptor activation.
Fedor-Chaiken M; Hein PW; Stewart JC; Brackenbury R; Kinch MS
Cell Commun Adhes; 2003; 10(2):105-18. PubMed ID: 14681060
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
Kapoor GS; Kapitonov D; O'Rourke DM
Cancer Res; 2004 Sep; 64(18):6444-52. PubMed ID: 15374953
[TBL] [Abstract][Full Text] [Related]
14. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene.
Batra SK; Castelino-Prabhu S; Wikstrand CJ; Zhu X; Humphrey PA; Friedman HS; Bigner DD
Cell Growth Differ; 1995 Oct; 6(10):1251-9. PubMed ID: 8845302
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III.
Zeineldin R; Rosenberg M; Ortega D; Buhr C; Chavez MG; Stack MS; Kusewitt DF; Hudson LG
Mol Carcinog; 2006 Nov; 45(11):851-60. PubMed ID: 16788982
[TBL] [Abstract][Full Text] [Related]
17. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
Gardner DP; Shimizu N
J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
[TBL] [Abstract][Full Text] [Related]
18. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor (EGF) induces apoptosis in a transfected cell line expressing EGF receptor on its membrane.
Zhao X; Dai W; Zhu H; Zhang Y; Cao L; Ye Q; Lei P; Shen G
Cell Biol Int; 2006 Aug; 30(8):653-8. PubMed ID: 16750403
[TBL] [Abstract][Full Text] [Related]
20. Transactivation of E-cadherin is not involved in the activity of EGF receptor in colorectal carcinoma cells.
Sovová V; Kucerová D; Vojtechová M; Sloncová E; Tuhácková Z
Int J Oncol; 2004 Nov; 25(5):1459-64. PubMed ID: 15492839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]